What's new

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab,...

Next Article

Human medicines European public assessment report (EPAR): Trumenba, meningococca...

Related Posts

EMEA-002474-PIP02-18-M02

EMEA-002474-PIP02-18-M02

Jun 16, 2025  0

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 94, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 13, 2025  0